Skip to main content
Article thumbnail
Location of Repository

A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis

By Crystal Y. Chen, Dan Huang, Richard C. Wang, Ling Shen, Gucheng Zeng, Shuyun Yao, Yun Shen, Lisa Halliday, Jeff Fortman, Milton McAllister, Jim Estep, Robert Hunt, Daphne Vasconcelos, George Du, Steven A. Porcelli, Michelle H. Larsen, William R. Jacobs, Barton F. Haynes, Norman L. Letvin and Zheng W. Chen


The role of CD8 T cells in anti-tuberculosis immunity in humans remains unknown, and studies of CD8 T cell–mediated protection against tuberculosis in mice have yielded controversial results. Unlike mice, humans and nonhuman primates share a number of important features of the immune system that relate directly to the specificity and functions of CD8 T cells, such as the expression of group 1 CD1 proteins that are capable of presenting Mycobacterium tuberculosis lipids antigens and the cytotoxic/bactericidal protein granulysin. Employing a more relevant nonhuman primate model of human tuberculosis, we examined the contribution of BCG- or M. tuberculosis-elicited CD8 T cells to vaccine-induced immunity against tuberculosis. CD8 depletion compromised BCG vaccine-induced immune control of M. tuberculosis replication in the vaccinated rhesus macaques. Depletion of CD8 T cells in BCG-vaccinated rhesus macaques led to a significant decrease in the vaccine-induced immunity against tuberculosis. Consistently, depletion of CD8 T cells in rhesus macaques that had been previously infected with M. tuberculosis and cured by antibiotic therapy also resulted in a loss of anti-tuberculosis immunity upon M. tuberculosis re-infection. The current study demonstrates a major role for CD8 T cells in anti-tuberculosis immunity, and supports the view that CD8 T cells should be included in strategies for development of new tuberculosis vaccines and immunotherapeutics

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2000). A nonhuman primate model for preclinical testing of new tuberculosis vaccines.
  2. (2000). A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung.
  3. (2002). A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.
  4. (2002). Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections.
  5. (1984). Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin.
  6. (1998). An antimicrobial activity of cytolytic T cells mediated by granulysin.
  7. (2001). Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG.
  8. (2006). Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response.
  9. (2001). BCG: the challenge continues.
  10. (1999). CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool.
  11. (2001). CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.
  12. (2001). CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis.
  13. (2003). CD8+ T cells accumulate in the lungs of Mycobacterium tuberculosis-infected Kb-/-Db-/- mice, but provide minimal protection.
  14. (2004). Clinical latency and reactivation of AIDS-related mycobacterial infections.
  15. (2000). Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells.
  16. (1999). Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
  17. (2002). Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis.
  18. (2004). CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gammasecreting simian immunodeficiency virus-specific T cells.
  19. (1997). Differential effects of cytolytic T cell subsets on intracellular infection.
  20. (2001). Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research.
  21. (2006). Early events in Mycobacterium tuberculosis infection in cynomolgus macaques.
  22. (2005). Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study.
  23. (2007). Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis.
  24. (2008). Evaluation of safety, immunogenicity, and efficacy of live attenuated replicating and nonreplicating Mycobacterium tuberculosis vaccine candidates in non-human primates. Infect Immun.
  25. (2007). HIV infection and multidrug-resistant tuberculosis: the perfect storm.
  26. (2002). HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells.
  27. (2003). Human immunity to M. tuberculosis: T cell subsets and antigen processing.
  28. (2003). Immune biology of macaque lymphocyte populations during mycobacterial infection.
  29. (2008). Immune distribution and localization of phosphoantigen-specific Vgamma2Vdelta2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection.
  30. (1987). Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells.
  31. (2002). Induction of an AIDS virus-related tuberculosis-like disease in macaques: a model of simian Role
  32. (2007). Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1.
  33. (2003). Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo.
  34. (1992). Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.
  35. (2006). Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.
  36. (2005). Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early Tlymphocyte responses.
  37. (2005). Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.
  38. (1973). Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. Am Rev Respir Dis
  39. (1993). Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis.
  40. (2000). Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice.
  41. RolphMS,RaupachB,KobernickHH,CollinsHL,PerarnauB,etal.(2001)MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis.
  42. (2008). Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of
  43. (1989). T-cellmediated protection of mice against virulent Mycobacterium tuberculosis.
  44. (1995). The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
  45. (1987). The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis.
  46. (1996). The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease.
  47. (2001). The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice.
  48. (2006). The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
  49. (2008). Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.